Author/Creator: Berliba, E - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Berliba, E

1. DOP46 Extended induction treatment with mirikizumab in patients with moderately to severely active ulcerative colitis: results from a Phase 2 trial. (25th January 2019)

Authors:: Sandborn, W J; Ferrante, M; Bhandari, B R; Berliba, E; Hibi, T; D'Haens, G Geert R; Tuttle, J; Krueger, K; Friedrich, S; Durante, M; Arora, V; Feagan, B
Journal:: Journal of Crohn's and colitis
Issue:: Volume 13(2019)Supplement 1
Page Start:: S054
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. OP38 Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitis. (25th January 2019)

Authors:: D'Haens, G Geert R; Sandborn, W J; Ferrante, M; Bhandari, B R; Berliba, E; Hibi, T; Tuttle, J; Canavan, J B; Friedrich, S; Durante, M; Arora, V; Feagan, B
Journal:: Journal of Crohn's and colitis
Issue:: Volume 13(2019)Supplement 1
Page Start:: S026
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗